NCT07644780

Brief Summary

In collaboration with the Federal Government of Nigeria and Bauchi State, Nutrition International (NI) conducted a three-year implementation research study to assess whether adherence solutions - developed through a human-centered designed (HCD) approach - could improve adherence to multiple micronutrient supplementation (MMS) among pregnant women in Nigeria. These set of adherence solutions focused on strengthening the capacity of healthcare workers and community members, improving nutrition counselling within antenatal care, and engaging pregnant women' family members to support consistent MMS intake.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
2,601

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Mar 2024

Geographic Reach
1 country

3 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 7, 2024

Completed
10 months until next milestone

First Submitted

Initial submission to the registry

January 14, 2025

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 26, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 26, 2025

Completed
1 year until next milestone

First Posted

Study publicly available on registry

June 12, 2026

Completed
Last Updated

June 12, 2026

Status Verified

June 1, 2026

Enrollment Period

1.2 years

First QC Date

January 14, 2025

Last Update Submit

June 8, 2026

Conditions

Keywords

MMSAdherenceAntenatal carematernal supplementationNigeriamaternal nutritionpregnant womenimplementation researchANCMultiple Micronutrient Supplementation

Outcome Measures

Primary Outcomes (1)

  • Adherence to MMS

    Defined as "when pregnant women consume the right dose of multiple micronutrient supplementation (MMS) at the right time throughout pregnancy". Measured through self-reported daily consumption, self-reported average consumption rate over a three-month period, and pill count.

    At baseline and approximately 2 years after (endline)

Secondary Outcomes (1)

  • Acceptability

    At baseline and approximately 2 years after (endline)

Study Arms (2)

Control arm

NO INTERVENTION

Intervention Arm

EXPERIMENTAL

Eligible pregnant women received implementation approaches

Behavioral: Implementation Approaches

Interventions

Implementation approaches are human-centered designed strategies aimed at optimizing pregnant women's daily adherence to MMS.

Intervention Arm

Eligibility Criteria

Age15 Years+
Sexfemale
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Pregnant/post-partum women
  • Women of reproductive age (15-49 years of age)
  • Pregnant or up to 3 months post-partum women
  • Having reportedly received at least one MMS bottle at least 30 days before start of data collection from a participating public health facility-
  • Provide consent for participation
  • Health Care Workers (HCWs)
  • HCWs providing ANC services including MMS and IFAs to pregnant women at the selected health facilities
  • Husbands
  • Husbands of the enrolled pregnant women At endline, the same criteria apply.

You may not qualify if:

  • Anemic pregnant women

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Public health facilities in Dass

Dass, Bauchi, Nigeria

Location

Public health facilities in Ganjuwa

Ganjuwa, Bauchi, Nigeria

Location

Public health facilities in Giade

Giade, Bauchi, Nigeria

Location

Study Officials

  • Babajide Adebisi

    Nutrition International

    PRINCIPAL INVESTIGATOR
  • Jennifer Busch Hallen

    Nutrition International

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 14, 2025

First Posted

June 12, 2026

Study Start

March 7, 2024

Primary Completion

May 26, 2025

Study Completion

May 26, 2025

Last Updated

June 12, 2026

Record last verified: 2026-06

Data Sharing

IPD Sharing
Will share

Published IPD will be shared upon reasonable request

Time Frame
May 2026 for 3 years.
Access Criteria
Access to the data will be restricted to the data collectors and study team, both of whom will sign a confidentiality agreement. When transmitting this data to investigators approved for this study, anonymized datasets will then be sent by encrypted zipped file in Stata format, The password to access these files will be communicated separately using email. The encryption keys will be transferred in the same way to co-investigators, if and as needed.

Locations